| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
173,970,000 |
| Market
Cap: |
5.06(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$13.29 - $43.89 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile BridegeBio Pharma identifies and improves medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Co.'s pipeline are: Acoramidis/AG10/BBP-265, a small molecule transthyretin (TTR) stabilizer for the treatment of TTR amyloidosis; Infigratinib/BBP-831, an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of achondroplasia; BBP-631, a preclinical adeno-associated virus gene transfer for the treatment of congenital adrenal hyperplasia; and Encaleret, a small molecule antagonist of the calcium sensing receptor for the treatment of Autosomal Dominant Hypocalcemia Type 1.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
5,415 |
192,897 |
1,845,608 |
2,886,602 |
| Total Sell Value |
$195,041 |
$7,018,061 |
$62,779,686 |
$73,415,196 |
| Total People Sold |
2 |
5 |
6 |
6 |
| Total Sell Transactions |
2 |
10 |
16 |
29 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Homcy Charles J |
Director |
– • – |
2022-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,210,742 |
|
- |
|
| Scheller Richard H |
Director |
– • – |
2022-08-16 |
4 |
D |
$11.08 |
$12,199 |
D/D |
(1,101) |
49,840 |
|
- |
|
| Scheller Richard H |
Director |
– • – |
2022-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,196 |
50,941 |
|
- |
|
| Kumar Neil |
CEO and President |
• • – |
2022-08-16 |
4 |
D |
$11.08 |
$306,883 |
D/D |
(27,697) |
4,813,197 |
|
- |
|
| Kumar Neil |
CEO and President |
• • – |
2022-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
68,705 |
4,840,894 |
|
- |
|
| Stephenson Brian C |
Secretary, Treasurer & CFO |
• – – |
2022-08-16 |
4 |
D |
$11.08 |
$102,235 |
D/D |
(9,227) |
341,260 |
|
- |
|
| Stephenson Brian C |
Secretary, Treasurer & CFO |
• – – |
2022-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,680 |
350,487 |
|
- |
|
| Stephenson Brian C |
See Remarks |
• – – |
2022-05-16 |
4 |
D |
$6.74 |
$62,197 |
D/D |
(9,228) |
323,807 |
|
- |
|
| Stephenson Brian C |
See Remarks |
• – – |
2022-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,680 |
333,035 |
|
- |
|
| Scheller Richard H |
Director |
– • – |
2022-05-16 |
4 |
D |
$6.74 |
$8,829 |
D/D |
(1,310) |
47,745 |
|
- |
|
| Scheller Richard H |
Director |
– • – |
2022-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,195 |
49,055 |
|
- |
|
| Homcy Charles J |
Director |
– • – |
2022-05-16 |
4 |
D |
$6.74 |
$10,386 |
D/D |
(1,541) |
1,206,982 |
|
- |
|
| Homcy Charles J |
Director |
– • – |
2022-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,759 |
1,208,523 |
|
- |
|
| Kumar Neil |
CEO and President |
• • – |
2022-05-16 |
4 |
D |
$6.74 |
$160,136 |
D/D |
(23,759) |
4,772,189 |
|
- |
|
| Kumar Neil |
CEO and President |
• • – |
2022-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
68,705 |
4,795,948 |
|
- |
|
| Ellis Andrea |
Director |
– • – |
2022-03-15 |
4 |
B |
$8.39 |
$100,680 |
D/D |
12,000 |
12,000 |
2.39 |
30% |
|
| Dachille Douglas A. |
Director |
– • – |
2022-03-14 |
4 |
B |
$8.19 |
$81,934 |
I/I |
10,000 |
20,000 |
2.1 |
23% |
|
| Stephenson Brian C |
See Remarks |
• – – |
2022-02-16 |
4 |
D |
$8.84 |
$9,017 |
D/D |
(1,020) |
306,355 |
|
- |
|
| Stephenson Brian C |
See Remarks |
• – – |
2022-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,488 |
307,375 |
|
- |
|
| Kumar Neil |
CEO and President |
• • – |
2022-02-16 |
4 |
D |
$8.84 |
$27,271 |
D/D |
(3,085) |
4,727,243 |
|
- |
|
| Kumar Neil |
CEO and President |
• • – |
2022-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,524 |
4,730,328 |
|
- |
|
| Dachille Douglas A. |
Director |
– • – |
2022-01-05 |
4 |
B |
$15.91 |
$79,550 |
I/I |
5,000 |
10,000 |
2.1 |
-55% |
|
| Dachille Douglas A. |
Director |
– • – |
2022-01-04 |
4 |
B |
$16.82 |
$84,100 |
I/I |
5,000 |
5,000 |
2.1 |
-59% |
|
| Lo Andrew |
Director |
– • – |
2021-12-30 |
4 |
B |
$14.30 |
$21,450 |
D/D |
1,500 |
48,099 |
2.39 |
-58% |
|
| Daniels Ronald J |
Director |
– • – |
2021-12-30 |
4 |
B |
$14.34 |
$149,165 |
D/D |
10,402 |
10,402 |
2.39 |
-58% |
|
288 Records found
|
|
Page 4 of 12 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.37 (1.29%) 
